Procurement for medicinal products including generics, branded generics, and proprietary pharmaceuticals under Group 18 classification.
NHS is establishing a branded medicines framework agreement across English regions, with two separate lots for different geographical areas and contract durations starting September 2026.
Opportunity to supply Ustekinumab, an immunosuppressant biopharmaceutical medication for various therapeutic applications.
NHS is seeking suppliers for branded medicines across England in two regional lots, with framework agreements commencing September 2026.
